NunaBio

NunaBio is a pioneering synthetic biology CDMO leveraging a proprietary, cell-free DNA manufacturing platform to produce high-complexity DNA constructs rapidly and at scale. Founded in 2021 and based in Newcastle upon Tyne, UK, the company addresses critical bottlenecks in DNA supply for the biotechnology industry, enabling partners to innovate without the constraints of traditional, cell-based manufacturing processes. Its award-winning, multi-patented technology focuses on sustainability, reducing environmental impact through cleaner processes. Backed by multi-million-pound funding and grants, NunaBio is positioning itself as a key infrastructure player for the future of distributed, software-driven biomanufacturing.

Proprietary, modular, cell-free DNA synthesis platform designed as a universal, software-orchestrated micro-foundry for producing high-complexity DNA constructs at scale without process redevelopment.

NunaBio competes with large, established DNA synthesis CDMOs like Twist Bioscience and GenScript, as well as traditional fermentation-based plasmid DNA manufacturers. Its differentiation lies in its cell-free approach, emphasis on high-complexity sequences without re-engineering, rapid turnaround, and sustainable process claims.